Financials
Financial year 2025
CeeMCee Pharma Consulting from Zoersel, company number BE0525652007, closed financial year 2025 with a result of € 62,418 after tax. For that financial year CeeMCee Pharma Consulting recorded a gross margin of € 94,921 and equity of € 237,984. Compared with financial year 2024, the result moved from € 64,517 to € 62,418. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.
€ 237,984
▲ 21% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 62,418
▼ 3% vs 2024
Profit after tax over the fiscal year.
€ 211,369
▲ 32% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 21,042 paid out
34 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 20,838
▲ 82% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 3
▼ 97% vs 2024
Loans from banks and other lenders, long and short.
€ 787
▼ 78% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 25,454
▲ 79% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 109,617 | € 65,670 | € 97,761 | € 94,921 | ▼ 3% |
| Profit after taxes | € 71,851 | € 43,547 | € 64,517 | € 62,418 | ▼ 3% |
| Equity | € 142,831 | € 152,092 | € 196,609 | € 237,984 | ▲ 21% |
| Total debts | € 23,511 | € 41,114 | € 31,971 | € 43,793 | ▲ 37% |
| Cash | € 110,596 | € 138,309 | € 160,652 | € 211,369 | ▲ 32% |
| Land & buildings | € 4,598 | € 2,581 | € 564 | € 202 | ▼ 64% |
| Retained profit | € 124,231 | € 133,492 | € 178,009 | € 219,384 | ▲ 23% |
| Dividend | € 4,108 | € 34,286 | € 20,000 | € 21,042 | ▲ 5% |
| Bank debt | € 0 | € 0 | € 111 | € 3 | ▼ 97% |
| Balance sheet total | € 166,342 | € 193,206 | € 228,580 | € 281,777 | ▲ 23% |
Key figures of CeeMCee Pharma Consulting, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CeeMCee Pharma Consulting?
What happened at CeeMCee Pharma Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 62,418 (▼ 3% vs 2024). Source: NBB ↗
- New establishment in Zoersel. KBO
- Start of the company according to the CBE. KBO
- Geertje Van Beeck became a director. NBB
In short
From € 71,851 profit in 2022 to € 62,418 profit in 2025.
Paid € 86,629 in corporate taxes since 2022.
Best year ever: 2022, with € 71,851 profit.
Paid out € 79,436 in dividends to the owners in total.
A new publication or filing at CeeMCee Pharma Consulting? We notify you, reason included.
Follow CeeMCee Pharma ConsultingDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind CeeMCee Pharma Consulting is Geertje Van Beeck.
Directors
According to the 2025 annual accounts
Geertje Van Beeck
Director
since 2013
Establishments
Establishment units
Physical locations of this company
Amazonelaan 26
2980 Zoersel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0525.652.007
- VAT number
- BE 0525.652.007
- Registered office
- Amazonelaan 26, 2980 Zoersel
- Names & denominations
- CeeMCee Pharma Consulting
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 April 2013
- Peppol
- Active · Active since 5 Nov 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied